Have any questions?
+44 1234 567 890
Publications
Bibliometrics
Manuel Mattheisen, as of October 2026. Citation figures from Scopus.
Full record: ORCID 0000-0002-8442-493X
by Manuel Mattheisen
Genome-wide association study of major anxiety disorders in 122,341 European-ancestry cases identifies 58 loci and highlights GABAergic signaling.
by Manuel Mattheisen
Mapping the genetic landscape across 14 psychiatric disorders.
by Manuel Mattheisen
Leveraging transdiagnostic genetic liability to psychiatric disorders to dissect clinical outcomes of anorexia nervosa.
by Manuel Mattheisen
Genome-Wide Association Study of Symptom Change Following Cognitive Behavioral Therapy for Common Mental Disorders.
by Manuel Mattheisen
Mental health stigma in Latin American youth with obsessive-compulsive disorder.
by Manuel Mattheisen
Methylome-Wide Association Study of Obsessive-Compulsive Disorder.
by Manuel Mattheisen
Genome-wide meta-analysis of quantitatively measured generalized anxiety symptoms in individuals of European ancestry.
by Manuel Mattheisen
Genomic meta-analyses of binge-eating behavior and anorexia nervosa yield insights into the unique and shared biology of eating disorder phenotypes.
by Manuel Mattheisen
Frequency and Self-Reported Outcomes of Transcranial Magnetic Stimulation for Obsessive Compulsive Disorder in the U.S. and Latin America.
by Manuel Mattheisen
Persistent tic disorders are associated with 17q12 duplications.
by Manuel Mattheisen
Predictors of quality of life in OCD: Machine-derived features beyond expert consensus.
by Manuel Mattheisen
Cross-Ancestry Polygenic Prediction of Bipolar Disorder and Obsessive-Compulsive Disorder in India.
by Manuel Mattheisen
Latinos interest in knowing and using genetic risk information about obsessive compulsive disorder.
by Manuel Mattheisen
Causal inference in psychiatric research: how to critically evaluate and interpret mendelian randomization studies.
by Manuel Mattheisen
Genome-Wide Association Study Meta-Analysis of 9619 Cases With Tic Disorders.
by Manuel Mattheisen
Genome-wide analyses identify 30 loci associated with obsessive–compulsive disorder.
by Manuel Mattheisen
The Impact of Parental Mental Health Diagnoses, Trauma, and Coping Mechanisms on Their Children's Well-Being.
by Manuel Mattheisen
A burden of rare copy number variants in obsessive-compulsive disorder.
by Manuel Mattheisen
Genomics yields biological and phenotypic insights into bipolar disorder.
by Manuel Mattheisen
Association Between Polygenic Risk and Symptom Severity Change After Cognitive Behavioral Therapy for Obsessive-Compulsive Disorder.
by Manuel Mattheisen
Psychometric properties of the Spanish Yale-Brown Obsessive-Compulsive Scale - Second Edition.
by Manuel Mattheisen
Genetic Architecture and Risk of Childhood Maltreatment Across 5 Psychiatric Diagnoses.
by Manuel Mattheisen
Benchmarking empirical severity for the Yale-Brown Obsessive Compulsive Scale-Second Edition.
by Manuel Mattheisen
Polygenic prediction of body mass index and obesity through the life course and across ancestries.
by Manuel Mattheisen
Transdiagnostic Links of Reward Processing in Obsessive-Compulsive Disorder and Depression.
by Manuel Mattheisen
Polygenic scores and symptom severity change after internet-delivered cognitive behaviour therapy for depression and anxiety.
by Manuel Mattheisen
Assessment and ascertainment in psychiatric molecular genetics: challenges and opportunities for cross-disorder research.
by Manuel Mattheisen
Functional Genomics Studies of Psychiatric Disorders in Individuals of Latin American Populations: A Scoping Review.
by Manuel Mattheisen
Latin American Trans-ancestry INitiative for OCD genomics (LATINO): Study protocol.
by Manuel Mattheisen
A polygenic resilience score moderates the genetic risk for schizophrenia: Replication in 18,090 cases and 28,114 controls from the Psychiatric Genomics Consortium.
by Manuel Mattheisen
The genetic architecture of youth anxiety: a study protocol.
by Manuel Mattheisen
Lithium response in bipolar disorder is associated with focal adhesion and PI3K-Akt networks: a multi-omics replication study.
by Manuel Mattheisen
Genome-Wide Association Study of Obsessive-Compulsive Symptoms including 33,943 individuals from the general population.
by Manuel Mattheisen
Shared Genetic Architecture Between Schizophrenia and Anorexia Nervosa: A Cross-trait Genome-Wide Analysis.
by Manuel Mattheisen
Distinct genetic liability profiles define clinically relevant patient strata across common diseases.
by Manuel Mattheisen
Genetic Epidemiology and Molecular Genetics.
by Manuel Mattheisen
The Relationship of Attention-Deficit/Hyperactivity Disorder With Posttraumatic Stress Disorder: A Two-Sample Mendelian Randomization and Population-Based Sibling Comparison Study.
by Manuel Mattheisen
Genome-wide association study of school grades identifies genetic overlap between language ability, psychopathology and creativity.
by Manuel Mattheisen
Polygenic risk score-based phenome-wide association study identifies novel associations for Tourette syndrome.
by Manuel Mattheisen
Using brain cell-type-specific protein interactomes to interpret neurodevelopmental genetic signals in schizophrenia.
by Manuel Mattheisen
Polygenic risk prediction: why and when out-of-sample prediction R2 can exceed SNP-based heritability.
by Manuel Mattheisen
Depression pathophysiology, risk prediction of recurrence and comorbid psychiatric disorders using genome-wide analyses.
by Manuel Mattheisen
Schizophrenia-associated somatic copy-number variants from 12,834 cases reveal recurrent NRXN1 and ABCB11 disruptions.
by Manuel Mattheisen
Swedish multimodal cohort of patients with anxiety or depression treated with internet-delivered psychotherapy (MULTI-PSYCH).
by Manuel Mattheisen
The Genetic Architecture of Obsessive-Compulsive Disorder: Contribution of Liability to OCD From Alleles Across the Frequency Spectrum.
by Manuel Mattheisen
Identification of shared and differentiating genetic architecture for autism spectrum disorder, attention-deficit hyperactivity disorder and case subgroups.
by Manuel Mattheisen
Sex-Dependent Shared and Nonshared Genetic Architecture Across Mood and Psychotic Disorders.
by Manuel Mattheisen
Elevated common variant genetic risk for tourette syndrome in a densely-affected pedigree.
by Manuel Mattheisen
Dissecting the Shared Genetic Architecture of Suicide Attempt, Psychiatric Disorders, and Known Risk Factors.
by Manuel Mattheisen
Interaction Testing and Polygenic Risk Scoring to Estimate the Association of Common Genetic Variants With Treatment Resistance in Schizophrenia.
by Manuel Mattheisen
The role of early-life family composition and parental socio-economic status as risk factors for obsessive-compulsive disorder in a Danish national cohort.
by Manuel Mattheisen
Mapping genomic loci implicates genes and synaptic biology in schizophrenia.
by Manuel Mattheisen
Genetic architecture of 11 major psychiatric disorders at biobehavioral, functional genomic and molecular genetic levels of analysis.
by Manuel Mattheisen
A Saturated Map of Common Genetic Variants Associated with Human Height from 5.4 Million Individuals of Diverse Ancestries.
by Manuel Mattheisen
Penetrance and Pleiotropy of Polygenic Risk Scores for Schizophrenia, Bipolar Disorder, and Depression Among Adults in the US Veterans Affairs Health Care System.
by Manuel Mattheisen
Concerns about the use of polygenic embryo screening for psychiatric and cognitive traits.
by Manuel Mattheisen
Identifying the Common Genetic Basis of Antidepressant Response.
by Manuel Mattheisen
Statistical and functional convergence of common and rare genetic influences on autism at chromosome 16p.
by Manuel Mattheisen
Meta-analysis of genome-wide association studies of hoarding symptoms in 27,537 individuals.
by Manuel Mattheisen
Genomics and Epigenomics of anxiety and obsessive-compulsive disorders.
by Manuel Mattheisen
Polygenic Heterogeneity Across Obsessive-Compulsive Disorder Subgroups Defined by a Comorbid Diagnosis.
by Manuel Mattheisen
Exemplar scoring identifies genetically separable phenotypes of lithium responsive bipolar disorder.
by Manuel Mattheisen
Prediction of lithium response using genomic data.
by Manuel Mattheisen
Genome-wide association study of pediatric obsessive-compulsive traits: shared genetic risk between traits and disorder.
by Manuel Mattheisen
Examining Sex-Differentiated Genetic Effects Across Neuropsychiatric and Behavioral Traits.
by Manuel Mattheisen
Investigating Shared Genetic Basis Across Tourette Syndrome and Comorbid Neurodevelopmental Disorders Along the Impulsivity-Compulsivity Spectrum.
by Manuel Mattheisen
Antipsychotics in routine treatment are minor contributors to QT prolongation compared to genetics and age.
by Manuel Mattheisen
Genome-wide association study of more than 40,000 bipolar disorder cases provides new insights into the underlying biology.
by Manuel Mattheisen
A Comparison of Ten Polygenic Score Methods for Psychiatric Disorders Applied Across Multiple Cohorts.
by Manuel Mattheisen
The Genetic Architecture of Depression in Individuals of East Asian Ancestry: A Genome-Wide Association Study.
by Manuel Mattheisen
A Mobile Sensing App to Monitor Youth Mental Health: Observational Pilot Study.
by Manuel Mattheisen
What Have We Learned About the Genetics of Obsessive-Compulsive and Related Disorders in Recent Years?
by Manuel Mattheisen
Genotype-phenotype feasibility studies on khat abuse, traumatic experiences and psychosis in Ethiopia.
by Manuel Mattheisen
Chronicity and Sex Affect Genetic Risk Prediction in Schizophrenia.
by Manuel Mattheisen
The Genetics of the Mood Disorder Spectrum: Genome-wide Association Analyses of More Than 185,000 Cases and 439,000 Controls.
by Manuel Mattheisen
Genome-wide gene-environment analyses of major depressive disorder and reported lifetime traumatic experiences in UK Biobank.
by Manuel Mattheisen
Large-Scale Exome Sequencing Study Implicates Both Developmental and Functional Changes in the Neurobiology of Autism.
by Manuel Mattheisen
Shared genetic risk between eating disorder- and substance-use-related phenotypes: Evidence from genome-wide association studies.
by Manuel Mattheisen
Classical Human Leukocyte Antigen Alleles and C4 Haplotypes Are Not Significantly Associated With Depression.
by Manuel Mattheisen
A major role for common genetic variation in anxiety disorders.
by Manuel Mattheisen
Association of polygenic score for major depression with response to lithium in patients with bipolar disorder.
by Manuel Mattheisen
Genetic identification of cell types underlying brain complex traits yields insights into the etiology of Parkinson's disease.
by Manuel Mattheisen
A phenome-wide association and Mendelian Randomisation study of polygenic risk for depression in UK Biobank.
by Manuel Mattheisen
Genome-wide meta-analysis of problematic alcohol use in 435,563 individuals yields insights into biology and relationships with other traits.
by Manuel Mattheisen
Complement genes contribute sex-biased vulnerability in diverse disorders.
by Manuel Mattheisen
Genetic Variants Associated With Anxiety and Stress-Related Disorders: A Genome-Wide Association Study and Mouse-Model Study.
by Manuel Mattheisen
Effects of BDNF Val66Met genotype and schizophrenia familial risk on a neural functional network for cognitive control in humans.
by Manuel Mattheisen
Genetics of response to cognitive behavior therapy in adults with major depression: a preliminary report.
by Manuel Mattheisen
Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder.
by Manuel Mattheisen
Disentangling polygenic associations between attention-deficit/hyperactivity disorder, educational attainment, literacy and language.
by Manuel Mattheisen
Genome-wide association study of antidepressant treatment resistance in a population-based cohort using health service prescription data and meta-analysis with GENDEP.
by Manuel Mattheisen
Quantifying between-cohort and between-sex genetic heterogeneity in major depressive disorder.
by Manuel Mattheisen
Population-based identity-by-descent mapping combined with exome sequencing to detect rare risk variants for schizophrenia.
by Manuel Mattheisen
Identification of common genetic risk variants for autism spectrum disorder.
by Manuel Mattheisen
Genetic Markers of ADHD-Related Variations in Intracranial Volume.
by Manuel Mattheisen
Gene expression imputation across multiple brain regions provides insights into schizophrenia risk.
by Manuel Mattheisen
Genetic Overlap Between Alzheimer's Disease and Bipolar Disorder Implicates the MARK2 and VAC14 Genes.
by Manuel Mattheisen
Genome-wide association study identifies 30 loci associated with bipolar disorder.
by Manuel Mattheisen
Integrated analysis of environmental and genetic influences on cord blood DNA methylation in new-borns.
by Manuel Mattheisen
Genome-wide association study identifies eight risk loci and implicates metabo-psychiatric origins for anorexia nervosa.
by Manuel Mattheisen
Nordic OCD & Related Disorders Consortium: Rationale, design, and methods.
by Manuel Mattheisen
A polygenic resilience score moderates the genetic risk for schizophrenia.
by Manuel Mattheisen
RICOPILI: Rapid Imputation for COnsortias PIpeLIne.
by Manuel Mattheisen
Genetic architecture of subcortical brain structures in 38,851 individuals.
by Manuel Mattheisen
1,25-Dihydroxyvitamin D modulates L-type voltage-gated calcium channels in a subset of neurons in the developing mouse prefrontal cortex.
by Manuel Mattheisen
Genome-wide association study of panic disorder reveals genetic overlap with neuroticism and depression.
by Manuel Mattheisen
Bipolar multiplex families have an increased burden of common risk variants for psychiatric disorders.
by Manuel Mattheisen
Autosomal-dominant hypotrichosis with woolly hair: Novel gene locus on chromosome 4q35.1-q35.2.
by Manuel Mattheisen
Genomic Relationships, Novel Loci, and Pleiotropic Mechanisms across Eight Psychiatric Disorders.
by Manuel Mattheisen
Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression.
by Manuel Mattheisen
Examination of the shared genetic basis of anorexia nervosa and obsessive-compulsive disorder.
by Manuel Mattheisen
Detecting significant genotype-phenotype association rules in bipolar disorder: market research meets complex genetics.
by Manuel Mattheisen
Gene set enrichment analysis and expression pattern exploration implicate an involvement of neurodevelopmental processes in bipolar disorder.
by Manuel Mattheisen
A Genetic Investigation of Sex Bias in the Prevalence of Attention-Deficit/Hyperactivity Disorder.
by Manuel Mattheisen
Common schizophrenia alleles are enriched in mutation-intolerant genes and in regions under strong background selection.
by Manuel Mattheisen
Elevated polygenic burden for autism is associated with differential DNA methylation at birth.
by Manuel Mattheisen
Differential activity of transcribed enhancers in the prefrontal cortex of 537 cases with schizophrenia and controls.
by Manuel Mattheisen
Estimation of Genetic Correlation via Linkage Disequilibrium Score Regression and Genomic Restricted Maximum Likelihood.
by Manuel Mattheisen
Analysis of the Influence of microRNAs in Lithium Response in Bipolar Disorder.
by Manuel Mattheisen
Genomic Dissection of Bipolar Disorder and Schizophrenia, Including 28 Subphenotypes.
by Manuel Mattheisen
Analysis of shared heritability in common disorders of the brain.
by Manuel Mattheisen
Age at first birth in women is genetically associated with increased risk of schizophrenia.
by Manuel Mattheisen
Genetic risk for schizophrenia and autism, social impairment and developmental pathways to psychosis.
by Manuel Mattheisen
Association of Whole-Genome and NETRIN1 Signaling Pathway-Derived Polygenic Risk Scores for Major Depressive Disorder and White Matter Microstructure in the UK Biobank.
by Manuel Mattheisen
The Anorexia Nervosa Genetics Initiative (ANGI): Overview and methods.
by Manuel Mattheisen
Applying polygenic risk scoring for psychiatric disorders to a large family with bipolar disorder and major depressive disorder.
by Manuel Mattheisen
The association between neonatal vitamin D status and risk of schizophrenia.
by Manuel Mattheisen
Contribution of copy number variants to schizophrenia from a genome-wide study of 41,321 subjects.
by Manuel Mattheisen
Association of the polygenic risk score for schizophrenia with mortality and suicidal behavior - A Danish population-based study.
by Manuel Mattheisen
Body mass index change in gastrointestinal cancer and chronic obstructive pulmonary disease is associated with Dedicator of Cytokinesis 1.
by Manuel Mattheisen
The protocadherin 17 gene affects cognition, personality, amygdala structure and function, synapse development and risk of major mood disorders.
by Manuel Mattheisen
Functional neuroimaging effects of recently discovered genetic risk loci for schizophrenia and polygenic risk profile in five RDoC subdomains.
by Manuel Mattheisen
Novel genetic loci associated with hippocampal volume.
by Manuel Mattheisen
Identification of shared risk loci and pathways for bipolar disorder and schizophrenia.
by Manuel Mattheisen
Whole-exome sequencing of individuals from an isolated population implicates rare risk variants in bipolar disorder.
by Manuel Mattheisen
Genomewide Association Study of Alcohol Dependence Identifies Risk Loci Altering Ethanol-Response Behaviors in Model Organisms.
by Manuel Mattheisen
Genetic correlation between amyotrophic lateral sclerosis and schizophrenia.
by Manuel Mattheisen
Open chromatin profiling of human postmortem brain infers functional roles for non-coding schizophrenia loci.
by Manuel Mattheisen
Genome Wide Association Study (GWAS) between Attention Deficit Hyperactivity Disorder (ADHD) and Obsessive Compulsive Disorder (OCD).
by Manuel Mattheisen
Polygenic transmission disequilibrium confirms that common and rare variation act additively to create risk for autism spectrum disorders.
by Manuel Mattheisen
Meta-analysis of GWAS of over 16,000 individuals with autism spectrum disorder highlights a novel locus at 10q24.32 and a significant overlap with schizophrenia.
by Manuel Mattheisen
The 5-HTTLPR Polymorphism Affects Network-Based Functional Connectivity in the Visual-Limbic System in Healthy Adults.
by Manuel Mattheisen
Polygenic risk score and heritability estimates reveals a genetic relationship between ASD and OCD.
by Manuel Mattheisen
Revealing the complex genetic architecture of obsessive-compulsive disorder using meta-analysis.
by Manuel Mattheisen
Genetic Association of Major Depression With Atypical Features and Obesity-Related Immunometabolic Dysregulations.
by Manuel Mattheisen
Hair Cortisol in Twins: Heritability and Genetic Overlap with Psychological Variables and Stress-System Genes.
by Manuel Mattheisen
Does Childhood Trauma Moderate Polygenic Risk for Depression? A Meta-analysis of 5765 Subjects From the Psychiatric Genomics Consortium.
by Manuel Mattheisen
Analyzing the Role of MicroRNAs in Schizophrenia in the Context of Common Genetic Risk Variants.
by Manuel Mattheisen
Genome-wide association study reveals greater polygenic loading for schizophrenia in cases with a family history of illness.
by Manuel Mattheisen
Genetic variants associated with response to lithium treatment in bipolar disorder: a genome-wide association study.
by Manuel Mattheisen
Schizophrenia risk from complex variation of complement component 4.
by Manuel Mattheisen
Mortality Among Persons With Obsessive-Compulsive Disorder in Denmark.
by Manuel Mattheisen
Genetic influences on schizophrenia and subcortical brain volumes: large-scale proof of concept.
by Manuel Mattheisen
Genetic risk for autism spectrum disorders and neuropsychiatric variation in the general population.
by Manuel Mattheisen
DNA Methylation at the Neonatal State and at the Time of Diagnosis: Preliminary Support for an Association with the Estrogen Receptor 1, Gamma-Aminobutyric Acid B Receptor 1, and Myelin Oligodendrocyte Glycoprotein in Female Adolescent Patients with OCD.
by Manuel Mattheisen
Dysregulation of miRNA-9 in a Subset of Schizophrenia Patient-Derived Neural Progenitor Cells.
by Manuel Mattheisen
Identification of the BRD1 interaction network and its impact on mental disorder risk.
by Manuel Mattheisen
Altered Functional Subnetwork During Emotional Face Processing: A Potential Intermediate Phenotype for Schizophrenia.
by Manuel Mattheisen
Specific anxiety disorders and subsequent risk for bipolar disorder: a nationwide study.
by Manuel Mattheisen
Polygenic Risk Scores on the Association Between Infections and Schizophrenia.
by Manuel Mattheisen
Increased mortality among people with anxiety disorders: total population study.
by Manuel Mattheisen
Schizophrenia risk variants affecting microRNA function and site-specific regulation of NT5C2 by miR-206.
by Manuel Mattheisen
Identification of a Bipolar Disorder Vulnerable Gene CHDH at 3p21.1.
by Manuel Mattheisen
Nonsyndromic cleft lip with or without cleft palate and cancer: Evaluation of a possible common genetic background through the analysis of GWAS data.
by Manuel Mattheisen
Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.
by Manuel Mattheisen
No Reliable Association between Runs of Homozygosity and Schizophrenia in a Well-Powered Replication Study.
by Manuel Mattheisen
Novel genetic loci underlying human intracranial volume identified through genome-wide association.
by Manuel Mattheisen
Systematic Integration of Brain eQTL and GWAS Identifies ZNF323 as a Novel Schizophrenia Risk Gene and Suggests Recent Positive Selection Based on Compensatory Advantage on Pulmonary Function.
by Manuel Mattheisen
High loading of polygenic risk in cases with chronic schizophrenia.
by Manuel Mattheisen
Secondary depression in severe anxiety disorders: a population-based cohort study in Denmark.
by Manuel Mattheisen
Seasonality shows evidence for polygenic architecture and genetic correlation with schizophrenia and bipolar disorder.
by Manuel Mattheisen
Comparison between an alternative and the classic definition of chronic bronchitis in COPDGene.
by Manuel Mattheisen
Hypomethylation and increased expression of the putative oncogene ELMO3 are associated with lung cancer development and metastases formation.
by Manuel Mattheisen
Psychiatric genome-wide association study analyses implicate neuronal, immune and histone pathways.
by Manuel Mattheisen
Common genetic variants influence human subcortical brain structures.
by Manuel Mattheisen
Systems genetics identifies Sestrin 3 as a regulator of a proconvulsant gene network in human epileptic hippocampus.
by Manuel Mattheisen
Joint analysis of psychiatric disorders increases accuracy of risk prediction for schizophrenia, bipolar disorder, and major depressive disorder.
by Manuel Mattheisen
LD Score regression distinguishes confounding from polygenicity in genome-wide association studies.
by Manuel Mattheisen
Genome-wide association study and meta-analysis identify ISL1 as genome-wide significant susceptibility gene for bladder exstrophy.
by Manuel Mattheisen
Whole-genome association analysis of treatment response in obsessive-compulsive disorder.
by Manuel Mattheisen
Polygenic Risk Score, Parental Socioeconomic Status, Family History of Psychiatric Disorders, and the Risk for Schizophrenia: A Danish Population-Based Study and Meta-analysis.
by Manuel Mattheisen
MicroRNA hsa-miR-4717-5p regulates RGS2 and may be a risk factor for anxiety-related traits.
by Manuel Mattheisen
The association between lower educational attainment and depression owing to shared genetic effects? Results in ~25,000 subjects.
by Manuel Mattheisen
Genetic Differences in the Immediate Transcriptome Response to Stress Predict Risk-Related Brain Function and Psychiatric Disorders.
by Manuel Mattheisen
A Novel Locus for Ectodermal Dysplasia of Hair, Nail and Skin Pigmentation Anomalies Maps to Chromosome 18p11.32-p11.31.
by Manuel Mattheisen
New data and an old puzzle: the negative association between schizophrenia and rheumatoid arthritis.
by Manuel Mattheisen
Impact of a cis-associated gene expression SNP on chromosome 20q11.22 on bipolar disorder susceptibility, hippocampal structure and cognitive performance.
by Manuel Mattheisen
Diagnosed Anxiety Disorders and the Risk of Subsequent Anorexia Nervosa: A Danish Population Register Study.
by Manuel Mattheisen
Association of the OPRM1 Variant rs1799971 (A118G) with Non-Specific Liability to Substance Dependence in a Collaborative de novo Meta-Analysis of European-Ancestry Cohorts.
by Manuel Mattheisen
Modeling Linkage Disequilibrium Increases Accuracy of Polygenic Risk Scores.
by Manuel Mattheisen
Genome-wide analysis implicates microRNAs and their target genes in the development of bipolar disorder.
by Manuel Mattheisen
Obsessive-Compulsive Disorder and Autism Spectrum Disorders: Longitudinal and Offspring Risk.
by Manuel Mattheisen
A genome-wide association study identifies risk loci for spirometric measures among smokers of European and African ancestry.
by Manuel Mattheisen
Contrasting genetic architectures of schizophrenia and other complex diseases using fast variance-components analysis.
by Manuel Mattheisen
Genome-wide association study in obsessive-compulsive disorder: results from the OCGAS.
by Manuel Mattheisen
Genome-wide association study and mouse expression data identify a highly conserved 32 kb intergenic region between WNT3 and WNT9b as possible susceptibility locus for isolated classic exstrophy of the bladder.
by Manuel Mattheisen
Integrated pathway-based approach identifies association between genomic regions at CTCF and CACNB2 and schizophrenia.
by Manuel Mattheisen
Beyond GWAS in COPD: probing the landscape between gene-set associations, genome-wide associations and protein-protein interaction networks.
by Manuel Mattheisen
Convergent lines of evidence support CAMKK2 as a schizophrenia susceptibility gene.
by Manuel Mattheisen
Further evidence for the impact of a genome-wide-supported psychosis risk variant in ZNF804A on the Theory of Mind Network.
by Manuel Mattheisen
Genetic variation in the lymphotoxin-α (LTA)/tumour necrosis factor-α (TNFα) locus as a risk factor for idiopathic achalasia.
by Manuel Mattheisen
Efficient strategy for detecting gene × gene joint action and its application in schizophrenia.
by Manuel Mattheisen
A genetic deconstruction of neurocognitive traits in schizophrenia and bipolar disorder.
by Manuel Mattheisen
Gender-specific association of variants in the AKR1C1 gene with dimensional anxiety in patients with panic disorder: additional evidence for the importance of neurosteroids in anxiety?
by Manuel Mattheisen
The hypercholesterolemia-risk gene SORT1 facilitates PCSK9 secretion.
by Manuel Mattheisen
Genome-wide association study reveals two new risk loci for bipolar disorder.
by Manuel Mattheisen
Risk loci for chronic obstructive pulmonary disease: a genome-wide association study and meta-analysis.
by Manuel Mattheisen
Striatal response to reward anticipation: evidence for a systems-level intermediate phenotype for schizophrenia.
by Manuel Mattheisen
Replication of brain function effects of a genome-wide supported psychiatric risk variant in the CACNA1C gene and new multi-locus effects.
by Manuel Mattheisen
Identification of pathways for bipolar disorder: a meta-analysis.
by Manuel Mattheisen
Common genetic variants associated with resting oxygenation in chronic obstructive pulmonary disease.
by Manuel Mattheisen
Variability in working memory performance explained by epistasis vs polygenic scores in the ZNF804A pathway.
by Manuel Mattheisen
Investigation of the involvement of MIR185 and its target genes in the development of schizophrenia.
by Manuel Mattheisen
GWAS-based pathway analysis differentiates between fluid and crystallized intelligence.
by Manuel Mattheisen
αCaMKII autophosphorylation controls the establishment of alcohol drinking behavior.
by Manuel Mattheisen
Common variants in the HLA-DQ region confer susceptibility to idiopathic achalasia.
by Manuel Mattheisen
XRCC5 as a risk gene for alcohol dependence: evidence from a genome-wide gene-set-based analysis and follow-up studies in Drosophila and humans.
by Manuel Mattheisen
Analysis of t(9;17)(q33.2;q25.3) chromosomal breakpoint regions and genetic association reveals novel candidate genes for bipolar disorder.
by Manuel Mattheisen
Biological insights from 108 schizophrenia-associated genetic loci.
by Manuel Mattheisen
Epidemiology, genetics, and subtyping of preserved ratio impaired spirometry (PRISm) in COPDGene.
by Manuel Mattheisen
IREB2 and GALC are associated with pulmonary artery enlargement in chronic obstructive pulmonary disease.
by Manuel Mattheisen
Common and rare variant analysis in early-onset bipolar disorder vulnerability.
by Manuel Mattheisen
DNAH5 is associated with total lung capacity in chronic obstructive pulmonary disease.
by Manuel Mattheisen
Investigation of manic and euthymic episodes identifies state- and trait-specific gene expression and STAB1 as a new candidate gene for bipolar disorder.
by Manuel Mattheisen
Phenotypic and genetic heterogeneity among subjects with mild airflow obstruction in COPDGene.
by Manuel Mattheisen
Obsessive-compulsive disorder as a risk factor for schizophrenia: a nationwide study.
by Manuel Mattheisen
Airway wall thickness is increased in COPD patients with bronchodilator responsiveness.
by Manuel Mattheisen
Pneumothorax risk factors in smokers with and without chronic obstructive pulmonary disease.
by Manuel Mattheisen
Non-emphysematous chronic obstructive pulmonary disease is associated with diabetes mellitus.
by Manuel Mattheisen
Partitioning heritability of regulatory and cell-type-specific variants across 11 common diseases.
by Manuel Mattheisen
The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data.
by Manuel Mattheisen
Functional and genetic characterization of the non-lysosomal glucosylceramidase 2 as a modifier for Gaucher disease.
by Manuel Mattheisen
Genetic schizophrenia risk variants jointly modulate total brain and white matter volume.
by Manuel Mattheisen
Meta-analysis and brain imaging data support the involvement of VRK2 (rs2312147) in schizophrenia susceptibility.
by Manuel Mattheisen
Common variant at 16p11.2 conferring risk of psychosis.
by Manuel Mattheisen
No evidence for an involvement of copy number variation in ABCA13 in schizophrenia, bipolar disorder, or major depressive disorder.
by Manuel Mattheisen
Duplications in RB1CC1 are associated with schizophrenia; identification in large European sample sets.
by Manuel Mattheisen
Genome-wide study of association and interaction with maternal cytomegalovirus infection suggests new schizophrenia loci.
by Manuel Mattheisen
Improved detection of common variants associated with schizophrenia by leveraging pleiotropy with cardiovascular-disease risk factors.
by Manuel Mattheisen
Schizophrenia genetic variants are not associated with intelligence.
by Manuel Mattheisen
Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.
by Manuel Mattheisen
Allelic differences between Europeans and Chinese for CREB1 SNPs and their implications in gene expression regulation, hippocampal structure and function, and bipolar disorder susceptibility.
by Manuel Mattheisen
All SNPs are not created equal: genome-wide association studies reveal a consistent pattern of enrichment among functionally annotated SNPs.
by Manuel Mattheisen
On association analysis of rare variants under population substructure: an approach for the detection of subjects that can cause bias in the analysis - T opt: an outlier detection method.
by Manuel Mattheisen
Rare autosomal copy number variations in early-onset familial Alzheimer's disease.
by Manuel Mattheisen
Copy number variants in German patients with schizophrenia.
by Manuel Mattheisen
Functional impact of a recently identified quantitative trait locus for hippocampal volume with genome-wide support.
by Manuel Mattheisen
Candidate gene association study implicates p63 in the etiology of non syndromic bladder-exstrophy-epispadias complex.
by Manuel Mattheisen
Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs.
by Manuel Mattheisen
Integrated genome-wide pathway association analysis with INTERSNP.
by Manuel Mattheisen
Linkage-disequilibrium-based binning affects the interpretation of GWASs.
by Manuel Mattheisen
Association between schizophrenia and common variation in neurocan (NCAN), a genetic risk factor for bipolar disorder.
by Manuel Mattheisen
Genetic variation at the synaptic vesicle gene SV2A is associated with schizophrenia.
by Manuel Mattheisen
FZD6 encoding the Wnt receptor frizzled 6 is mutated in autosomal-recessive nail dysplasia.
by Manuel Mattheisen
Association between copy number variants in 16p11.2 and major depressive disorder in a German case-control sample.
by Manuel Mattheisen
Gene-based analysis of regionally enriched cortical genes in GWAS data sets of cognitive traits and psychiatric disorders.
by Manuel Mattheisen
A mega-analysis of genome-wide association studies for major depressive disorder.
by Manuel Mattheisen
Role of common and rare APP DNA sequence variants in Alzheimer disease.
by Manuel Mattheisen
Identification of common variants associated with human hippocampal and intracranial volumes.
by Manuel Mattheisen
Common variants at 12q14 and 12q24 are associated with hippocampal volume.
by Manuel Mattheisen
Runs of homozygosity implicate autozygosity as a schizophrenia risk factor.
by Manuel Mattheisen
DCLK1 variants are associated across schizophrenia and attention deficit / hyperactivity disorder.
by Manuel Mattheisen
Segment-wise genome-wide association analysis identifies a candidate region associated with schizophrenia in three independent samples.
by Manuel Mattheisen
Investigation of the genetic association between quantitative measures of psychosis and schizophrenia: a polygenic risk score analysis.
by Manuel Mattheisen
Neuregulin 3 is associated with attention deficits in schizophrenia and bipolar disorder.
by Manuel Mattheisen
Replication of functional serotonin receptor type 3A and B variants in bipolar affective disorder: a European multicenter study.
by Manuel Mattheisen
Genome-wide meta-analyses of non syndromic cleft lip with or without cleft palate identify six new risk loci.
by Manuel Mattheisen
Genome-wide association data provide further support for an association between 5-HTTLPR and major depressive disorder.
by Manuel Mattheisen
Studies in humans and mice implicate neurocan in the etiology of mania.
by Manuel Mattheisen
Quick, "imputation-free" meta-analysis with proxy-SNPs.
by Manuel Mattheisen
Genome-wide significant association between a 'negative mood delusions' dimension in bipolar disorder and genetic variation on chromosome 3q26.1.
by Manuel Mattheisen
Nine new twin pairs with esophageal atresia: a review of the literature and performance of a twin study of the disorder.
by Manuel Mattheisen
VATER/VACTERL association: identification of seven new twin pairs, a systematic review of the literature, and a classical twin analysis.
by Manuel Mattheisen
Association between genetic variation in a region on chromosome 11 and schizophrenia in large samples from Europe.
by Manuel Mattheisen
Significance levels in genome-wide interaction analysis (GWIA).
by Manuel Mattheisen
Resequencing and follow-up of neurexin 1 (NRXN1) in schizophrenia patients.
by Manuel Mattheisen
Genome-wide association study identifies genetic variation in neurocan as a susceptibility factor for bipolar disorder.
by Manuel Mattheisen
Genome-wide survey implicates the influence of copy number variants (CNVs) in the development of early-onset bipolar disorder.
by Manuel Mattheisen
The complement control-related genes CSMD1 and CSMD2 associate to schizophrenia.
by Manuel Mattheisen
Common variants at VRK2 and TCF4 conferring risk of schizophrenia.
by Manuel Mattheisen
Association of COMT genotypes with S-COMT promoter methylation in growth-discordant monozygotic twins and healthy adults.
by Manuel Mattheisen
Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4.
by Manuel Mattheisen
Genome-wide association study identifies five new schizophrenia loci.
by Manuel Mattheisen
Genome-wide significant association between alcohol dependence and a variant in the ADH gene cluster.
by Manuel Mattheisen
Hippocampal function in healthy carriers of the CLU Alzheimer's disease risk variant.
by Manuel Mattheisen
Genome-wide association study identifies two susceptibility loci for non syndromic cleft lip with or without cleft palate.
by Manuel Mattheisen
Expanding the range of ZNF804A variants conferring risk of psychosis.
by Manuel Mattheisen
Meta-analysis of genome-wide association data identifies a risk locus for major mood disorders on 3p21.1.
by Manuel Mattheisen
A reappraisal of the association between Dysbindin (DTNBP1) and schizophrenia in a large combined case-control and family-based sample of German ancestry.
by Manuel Mattheisen
Independent evidence for the selective influence of GABA(A) receptors on one component of the bipolar disorder phenotype.
by Manuel Mattheisen
The catechol-O-methyl transferase (COMT) gene and its potential association with schizophrenia: findings from a large German case-control and family-based sample.
by Manuel Mattheisen
Evidence for linkage of the bladder exstrophy-epispadias complex on chromosome 4q31.21-22 and 19q13.31-41 from a consanguineous Iranian family.
by Manuel Mattheisen
Genome-wide association-, replication-, and neuroimaging study implicates HOMER1 in the etiology of major depression.
by Manuel Mattheisen
Polymorphisms in SREBF1 and SREBF2, two antipsychotic-activated transcription factors controlling cellular lipogenesis, are associated with schizophrenia in German and Scandinavian samples.
by Manuel Mattheisen
Dissection of phenotype reveals possible association between schizophrenia and Glutamate Receptor Delta 1 (GRID1) gene promoter.
by Manuel Mattheisen
A novel locus for arterial hypertension on chromosome 1p36 maps to a metabolic syndrome trait cluster in the Sorbs, a Slavic population isolate in Germany.
by Manuel Mattheisen
The DISC locus and schizophrenia: evidence from an association study in a central European sample and from a meta-analysis across different European populations.
by Manuel Mattheisen
Common variants conferring risk of schizophrenia.
by Manuel Mattheisen
Supporting evidence for LRRTM1 imprinting effects in schizophrenia.
by Manuel Mattheisen
Genome-wide linkage scan of non syndromic orofacial clefting in 91 families of central European origin.
by Manuel Mattheisen
Inferential testing for linkage with GENEHUNTER-MODSCORE: the impact of the pedigree structure on the null distribution of multipoint MOD scores.
by Manuel Mattheisen
Brain-specific tryptophan hydroxylase 2 (TPH2): a functional Pro206Ser substitution and variation in the 5'-region are associated with bipolar affective disorder.
by Manuel Mattheisen
Linkage analysis using sex-specific recombination fractions with GENEHUNTER-MODSCORE.
by Manuel Mattheisen
Explorative two-locus linkage analysis suggests a multiplicative interaction between the 7q32 and 16p13 myoclonic seizures-related photosensitivity loci.
by Manuel Mattheisen
A German genome-wide linkage scan for type 2 diabetes supports the existence of a metabolic syndrome locus on chromosome 1p36.13 and a type 2 diabetes locus on chromosome 16p12.2.
by Manuel Mattheisen
High factor VIII levels in venous thromboembolism show linkage to imprinted loci on chromosomes 5 and 11.
by Manuel Mattheisen